Dergiler / Medicine Science / 2022 / Cilt: 11 - Sayı: 1

Evaluation of cardiovascular risk in people with rosacea: A prospective study

Sayfa
331–334
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

People with rosacea should be monitored periodically in terms of cardiovascular disease risk.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Systemic inflammation is accepted as a nontraditional cardiovascular risk factor and has been shown to play a role in all stages of atherosclerosis.
📊
Temel Bulgular & Veri:In our study, we aimed to evaluate the cardiovascular risk in rosacea patients. 40 people with rosacea (30 women, 10 men) and a control group of 40 age- and sex-matched individuals (28 women, 12 men) who had no chronic inflammatory skin disease were included in the study.
💡
Sonuç & Katkı:People with rosacea should be monitored periodically in terms of cardiovascular disease risk.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Systemic inflammation is accepted as a nontraditional cardiovascular risk factor and has been shown to play a role in all stages of atherosclerosis. Rosacea is a chronic inflammatory skin disease. In our study, we aimed to evaluate the cardiovascular risk in rosacea patients. 40 people with rosacea (30 women, 10 men) and a control group of 40 age- and sex-matched individuals (28 women, 12 men) who had no chronic inflammatory skin disease were included in the study. Participants' body mass index (BMI) was calculated and their blood pressure was measured. Fasting blood glucose, fasting blood insulin, lipid profile, hemogram, basic biochemical parameters, erythrocyte sedimentation rate, and C-reactive protein levels were analyzed after at least 8 hours of fasting. In all participants, carotid intima-media thickness (CIMT) was measured using high-resolution B-mode ultrasonography (with a 4 MHz linear transducer. The mean CIMT values were 0.62 (0.18) mm in the rosacea group and 0.50 (0.14) mm in the control group. Statistical comparison indicated that mean CIMT was significantly greater in the patients with rosacea compared to the control group (p=0.001). There was no significant difference between the rosacea and control groups in terms of mean height, weight, BMI, or systolic and diastolic blood pressures (p>0.05). People with rosacea should be monitored periodically in terms of cardiovascular disease risk.

🔖

Bu Makaleye Atıf Yap

AKYOL, M., GÜNER, R. Y., DİRİM, Y. C., TOSUN, M., TURGUT, İ. (2022). Evaluation of cardiovascular risk in people with rosacea: A prospective study. Medicine Science, Cilt: 11 - Sayı: 1, 331–334. https://ajindex.com/articles/579561

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Gupta AK, Chaudhry MM. Rosacea and its management: an overview. J Eur Acad Dermatol Venereol. 2005;19(e):273–85
  2. Rainer BM, Fischer AH, Da Silva LFD, et al. Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: Results of a case-control study. J Am Acad Dermatol. 2015;73:604–8
  3. Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Clustering of autoimmune diseases in patients with rosacea. J Am Acad Dermatol. 2016;74:667-72
  4. Duman N, Ersoy Evans S, et al. Rosacea and cardiovascular risk factors: A case control study. J Eur Acad Dermatology Venereol. 2014;28:1165–9
  5. Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea. report of the national rosacea society expert committee on the classification and staging of rosacea. J Am Acad Dermatol. 2002;46:584–7
  6. Expert Panel on Detection E and T of HBC in A. Executive Summary of the Third Report (NCEP) -Adult Treatment Panel III. J Am Med Assoc. 2001;285:2486–97
  7. Fimmel S, Abdel-Naser MB, Kutzner H, et al. New aspects of pathogenesis of rosacea. Drug Discov Today Dis Mech. 2008;5:103–11 8. Egeberg A, Fowler JF, Gislason GH, et al. Nationwide Assessment of Cause- Specific Mortality in Patients with Rosacea: A Cohort Study in Denmark. Am J Clin Dermatol. 2016;17:673–9
  8. Hua TC, Chung PI, Chen YJ, et al. Cardiovascular comorbidities in patients with rosacea: A nationwide case-control study from Taiwan. J Am Acad Dermatol. 2015;73:249–54
  9. Egeberg A, Hansen PR, Gislason GH, et al. Assessment of the risk of cardiovascular disease in patients with rosacea. J Am Acad Dermatol. 2016;75:336–9 11. Marshall VD, Moustafa F, Hawkins SD, et al. Cardiovascular Disease Outcomes Associated with Three Major Inflammatory Dermatologic Diseases: A Propensity-Matched Case Control Study. Dermatol Ther. 2016;6:649–58
  10. Mookadam F, Moustafa SE, Lester SJ, et al. Subclinical atherosclerosis: Evolving role of carotid Intima-Media thickness. Prev Cardiol. 2010;13:186–97
  11. Belli AA, Gok SO, Akbaba G, et al. The relationship between rosacea and insulin resistance and metabolic syndrome. Eur J Dermatology. 2016;26:260–4
  12. Gurel G, Turan Y. Noninvasive assessment of subclinical atherosclerosis in patients with rosacea. Ital J Dermatol Venerol. 2021;156:51-6
  13. Ertekin SS, Koku Aksu AE, Kocyigit A, et al. Carotid intima-media thickness and serum proinflammatory cytokine levels in rosacea patients without cardiovascular risk factors. Dermatol Ther. 2021;34:e14733. 16